iBio, Inc. Common Stock (IBIO)

Price$1.89

Value ScoreD

Growth ScoreF

Momentum ScoreC

Favorite Metrics

Price vs S&P 500 (26W)75.01%

Price vs S&P 500 (4W)14.53%

VGM Score36.85

Market Capitalization$94.39M

All Metrics

Book Value / Share (Quarterly)$2.24

P/TBV (Annual)1.02x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-40.30%

Cash Flow / Share (Quarterly)$-0.64

Price vs S&P 500 (YTD)-12.49%

Gross Margin (TTM)52.10%

Net Profit Margin (TTM)-3049.40%

EPS (TTM)$-0.83

10-Day Avg Trading Volume0.75M

EPS Excl Extra (TTM)$-0.83

Revenue Growth (5Y)-24.59%

EPS (Annual)$-1.75

ROI (Annual)-221.12%

Gross Margin (Annual)38.40%

Net Profit Margin (5Y Avg)-4064.26%

Cash / Share (Quarterly)$2.17

ROA (Last FY)-157.79%

Revenue Growth TTM (YoY)-20.00%

EBITD / Share (TTM)$-0.52

ROE (5Y Avg)-251.07%

Operating Margin (TTM)-3113.60%

Cash Flow / Share (Annual)$-36.87

P/B Ratio1.22x

P/B Ratio (Quarterly)0.85x

Net Income / Employee (Annual)$-918,800

EV / Revenue (TTM)93.52x

Net Interest Coverage (TTM)-9.05x

ROA (TTM)-46.48%

EPS Incl Extra (Annual)$-1.75

Current Ratio (Annual)1.22x

Quick Ratio (Quarterly)11.50x

3-Month Avg Trading Volume1.01M

52-Week Price Return143.09%

Revenue / Employee (TTM)$15,000

Tangible BV / Share (Quarterly)$2.19

P/S Ratio (Annual)235.97x

Asset Turnover (Annual)0.02x

52-Week High$3.82

Operating Margin (5Y Avg)-3157.90%

EPS Excl Extra (Annual)$-1.75

CapEx CAGR (5Y)-57.47%

Tangible BV CAGR (5Y)-7.29%

26-Week Price Return90.94%

Quick Ratio (Annual)1.19x

13-Week Price Return-38.11%

Total Debt / Equity (Annual)0.91x

Current Ratio (Quarterly)11.88x

Enterprise Value$46.76M

Revenue / Share Growth (5Y)-68.67%

Asset Turnover (TTM)0.01x

Book Value / Share Growth (5Y)-50.39%

Revenue / Employee (Annual)$20,000

Inventory Turnover (Annual)3.65x

Pretax Margin (Annual)-4594.25%

Cash / Share (Annual)$4.30

3-Month Return Std Dev87.34%

Gross Margin (5Y Avg)50.77%

Net Income / Employee (TTM)$-1,380,300

ROE (Last FY)-422.14%

Net Interest Coverage (Annual)-291.78x

EPS Basic Excl Extra (Annual)$-1.75

Receivables Turnover (TTM)0.00x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-0.83

Receivables Turnover (Annual)0.00x

ROI (TTM)-53.44%

P/S Ratio (TTM)188.78x

Pretax Margin (5Y Avg)-3001.85%

Revenue / Share (Annual)$0.04

Tangible BV / Share (Annual)$10.00

Price vs S&P 500 (52W)114.89%

Year-to-Date Return-1.55%

5-Day Price Return3.26%

EPS Normalized (Annual)$-1.75

ROA (5Y Avg)-59.82%

Net Profit Margin (Annual)-4594.25%

Month-to-Date Return12.43%

Cash Flow / Share (TTM)$-1.62

EBITD / Share (Annual)$-1.70

Operating Margin (Annual)-4650.50%

LT Debt / Equity (Annual)0.01x

ROI (5Y Avg)-75.76%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-0.83

P/TBV (Quarterly)0.87x

P/B Ratio (Annual)0.67x

Inventory Turnover (TTM)1.98x

Pretax Margin (TTM)-3049.40%

Book Value / Share (Annual)$15.40

Price vs S&P 500 (13W)-47.86%

Beta1.26x

Revenue / Share (TTM)$0.00

ROE (TTM)-53.86%

52-Week Low$0.56

vGradeD

gGradeF

mGradeC

vgmGradeD

Show chart for

Earnings Surprise History

Q3 26-0.07est. -0.06

Analyst Recommendations

Feb 2026

Mar 2026

Apr 2026

May 2026

4.27

4.25

Industry Peers — Pharmaceuticals(550)

Symbol	Value Score	Growth Score	Momentum Score	Price
IBIOiBio, Inc. Common Stock	D	F	C	$1.89
LLYEli Lilly & Co.	D	B	B	$1082.20
JNJJohnson & Johnson	C	C	C	$223.51
ABBVABBVIE INC.	D	C	C	$212.93
MRKMerck & Co., Inc.	C	C	C	$115.17
NVSNovartis AG	C	C	C	$145.68
AZNAstraZeneca PLC	D	B	C	$179.71
NVONovo-Nordisk A/S	B	B	C	$44.07
ABTAbbott Laboratories	C	C	D	$87.78
PFEPfizer Inc.	B	C	C	$25.63
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$34.64

About

iBio Inc is a preclinical-stage biotechnology company that uses artificial intelligence to develop precision antibodies and provide contract manufacturing services. The company's AI-driven platform employs epitope-steering and monoclonal antibody optimization to reduce development risk and accelerate time to clinic.